ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
3 more of Morgans' best ASX share ideas for March
Investing Strategies
You can't pick the bottom, but these 4 ASX shares are already bargains: expert
Healthcare Shares
2 ASX healthcare shares analysts rate as buys
Blue Chip Shares
Analysts name 3 ASX 200 shares with potential upside of 20%+
Growth Shares
Analysts name 2 ASX growth shares to buy
Blue Chip Shares
3 buy-rated ASX 200 shares
Blue Chip Shares
2 highly rated ASX 200 shares to buy immediately
Ask a Fund Manager
2 medical tech ASX shares for turbulent times
Blue Chip Shares
2 highly rated blue chip ASX 200 shares to buy
Broker Notes
Morgans names 4 more of the best ASX shares to buy in February
Growth Shares
3 fantastic ASX shares to buy this month
Broker Notes
Leading brokers name 3 ASX shares to buy today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
